Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
This grant funds the validation of high-quality markers for clinical studies in cancer.
About this program
The Assay Validation of High Quality Markers for Clinical Studies in Cancer grant aims to support research that focuses on the validation of biomarkers that can be used in clinical studies related to cancer. This grant is intended for researchers and institutions that are engaged in cancer research and are looking to enhance the reliability and effectiveness of clinical trials through improved assay techniques. The funding will facilitate the development and validation processes necessary to ensure that these markers meet the required standards for clinical application. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capability to conduct rigorous validation studies. The grant will support projects that demonstrate a clear methodology for assay validation and provide evidence of the potential impact on cancer research and treatment. By funding these projects, the grant aims to contribute to the advancement of cancer diagnostics and therapeutics, ultimately improving patient outcomes.
Eligibility
Academic institutions, nonprofit organizations, and research entities engaged in cancer research.